Dijagnostička i prognostička vrednost serumske laktat dehidrogenaze i amilaze u teškom akutnom pankreatitisu: klinička procena zasnovana na biohemiji

Serum LDH i AMI kao biohemijski prediktori SAP-a

  • Jie Zheng Kuzhou Povezana bolnica Medicinskog univerziteta Uenzhou, Kuzhou Narodna bolnica
  • Jin Wang Kuzhou Povezana bolnica Medicinskog univerziteta Uenzhou, Kuzhou Narodna bolnica
  • Yinong Zhou Kuzhou Povezana bolnica Medicinskog univerziteta Uenzhou, Kuzhou Narodna bolnica
  • Tingting Yu Kuzhou Povezana bolnica Medicinskog univerziteta Uenzhou, Kuzhou Narodna bolnica

Sažetak


Summary

Background: Severe acute pancreatitis (SAP) is characterized by extensive acinar-cell injury, metabolic dysregulation, and systemic inflammatory activation. Reliable biochemical markers for early risk stratification remain limited. Lactate dehydrogenase (LDH) and amylase (AMY), routinely measured enzymes reflecting cellular damage and pancreatic exocrine dysfunction, may provide prognostic value. To evaluate the diagnostic performance of serum LDH and AMY in identifying SAP and predicting short-term outcomes.

Methods: This retrospective study included 200 patients with acute pancreatitis. Serum LDH and AMY were measured on admission using standardized clinical chemistry assays with internal quality control. Patients were categorized as MAP, MSAP, or SAP, and SAP cases were further stratified into good and poor 2-week prognosis groups. Logistic regression and ROC analyses were used to determine the predictive value of LDH and AMY.

Results: LDH and AMY levels increased significantly with disease severity (P<0.05). Both biomarkers were independent predictors of SAP (LDH OR=1.644; AMY OR=1.670) and poor prognosis (LDH OR=1.684; AMY OR=1.730). Combined LDH+AMY demonstrated superior predictive accuracy for SAP (AUC=0.854) and short-term poor prognosis (AUC=0.884), outperforming individual markers.

Conclusions: Serum LDH and AMY are clinically valuable biochemical indicators for early identification of SAP and prediction of short-term outcomes. Their combined use significantly enhances diagnostic accuracy, supporting their integration into early biochemical risk assessment models.

Reference

1. Hong W, Zheng L, Lu Y, Qiu M, Yan Y, Basharat Z, et al. Non-linear correlation between amylase day 2 to day 1 ratio and incidence of severe acute pancreatitis. Front Cell Infect Mi 2022; 12(910760.
2. Shuanglian Y, Huiling Z, Xunting L, Yifang D, Yufen L, Shanshan X, et al. Establishment and validation of early prediction model for hypertriglyceridemic severe acute pancreatitis. Lipids Health Dis 2023; 22(1): 218.
3. Zhou W, Liu Q, Wang Z, Yao L, Chen J, Yang X. Analysis of the clinical profile and treatment efficiency of hyperlipidemic acute pancreatitis. Lipids Health Dis 2024; 23(1): 70.
4. Chen S, Song X, Lu J, Liang J, Ouyang H, Zheng W, et al. Application of alkaline phosphatase-to-hemoglobin and lactate dehydrogenase-to-hemoglobin ratios as novel noninvasive indices for predicting severe acute pancreatitis in patients. Plos One 2024; 19(11): e0312181.
5. Bush N, Rana SS. Ascites in Acute Pancreatitis: Clinical Implications and Management. Digest Dis Sci 2022; 67(6): 1987-93.
6. Barbieri JS, Riggio JM, Jaffe R. Amylase testing for abdominal pain and suspected acute pancreatitis. J Hosp Med 2016; 11(5): 366-8.
7. Ismail OZ, Bhayana V. Lipase or amylase for the diagnosis of acute pancreatitis? Clin Biochem 2017; 50(18): 1275-80.
8. Yang D, Lu H, Liu Y, Li M, Hu W, Zhou Z. Development and validation of a prediction model for moderately severe and severe acute pancreatitis in pregnancy. World J Gastroentero 2022; 28(15): 1588-600.
9. Rao J, Li J, Wu Y, Lai T, Zhou Z, Gong Y, et al. Ascites characteristics in acute pancreatitis: A prognostic indicator of organ failure and mortality. World J Gastroentero 2025; 31(28): 108926.
10. Lahiri D, Nag M, Banerjee R, Mukherjee D, Garai S, Sarkar T, et al. Amylases: Biofilm Inducer or Biofilm Inhibitor? Front Cell Infect Mi 2021; 11: 660048.
11. Wang Z, Liu Y, Zhang X, Wang C, Tian J, Zhao H, et al. Construction of a nomogram for hypertriglyceridemic severe acute pancreatitis that includes metabolic indexes. Lipids Health Dis 2025; 24(1): 279.
12. Tian F, Li H, Wang L, Li B, Aibibula M, Zhao H, et al. The diagnostic value of serum C-reactive protein, procalcitonin, interleukin-6 and lactate dehydrogenase in patients with severe acute pancreatitis. Clinica Chimica Acta; International Journal of Clinical Chemistry 2020; 510: 665-70.
13. Lu G, Pan Y, Kayoumu A, Zhang L, Yin T, Tong Z, et al. Indomethacin inhabits the NLRP3 inflammasome pathway and protects severe acute pancreatitis in mice. Biochem Bioph Res Co 2017; 493(1): 827-32.
14. Furey C, Buxbaum J, Chambliss AB. A review of biomarker utilization in the diagnosis and management of acute pancreatitis reveals amylase ordering is favored in patients requiring laparoscopic cholecystectomy. Clin Biochem 2020; 77: 54-6.
15. Morton A. Review article: Diagnosing acute pancreatitis in diabetes mellitus. Emergency Medicine Australasia : EMA 2022; 34(1): 6-8.
16. Wang X, Zhang Y. Diagnostic Value of Serum Amylase and Coagulation Function Indices in Distinguishing Acute Pancreatitis from Aortic Dissection. Clin Lab 2024; 70(9): 10-7754.
17. Boggio V, Gonzalez CD, Zotta E, Ropolo A, Vaccaro MI. VMP1 Constitutive Expression in Mice Dampens Pancreatic and Systemic Histopathological Damage in an Experimental Model of Severe Acute Pancreatitis. International Journal of Molecular Sciences 2025; 26(7): 3196.
18. Wang B, Huang D, Cao C, Gong Y. Insect α-Amylases and Their Application in Pest Management. Molecules 2023; 28(23): 7888.
19. Azzopardi E, Lloyd C, Teixeira SR, Conlan RS, Whitaker IS. Clinical applications of amylase: Novel perspectives. Surgery 2016; 160(1): 26-37.
20. Kumar V, Barkoudah E, Souza DAT, Jin DX, McNabb-Baltar J. Clinical course and outcome among patients with acute pancreatitis and COVID-19. Eur J Gastroen Hepat 2021; 33(5): 695-700.
21. Bengi G, Çelik İ, Dolu S, Önem S, Soytürk M, Rendeci S, et al. Neutrophil-Lymphocyte Ratio and LDH/Albumin Ratio as Biomarkers for Severity and Mortality in Acute Pancreatitis. The Turkish Journal of Gastroenterology: The Official Journal of Turkish Society of Gastroenterology 2025; 36(8): 497-507.
Objavljeno
2026/01/30
Broj časopisa
Rubrika
Original paper